Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-03 5:51 pm Purchase | 2024-08-23 | 13G | Whitehawk Therapeutics Inc WHWK | EcoR1 Capital, LLC | 1,845,253 7.500% | 1,845,253 (New Position) | Filing History |
| 2024-08-28 4:42 pm Purchase | 2024-08-28 | 13G | Whitehawk Therapeutics Inc WHWK | BML Investment Partners, L.P. | 1,383,817 5.600% | 1,383,817 (New Position) | Filing History |
| 2023-02-13 5:39 pm Sale | 2022-12-31 | 13G | Whitehawk Therapeutics Inc WHWK | Vivo Panda LLC | 509,572 2.100% | -218,095 (-29.97%) | Filing History |
| 2023-02-10 1:04 pm Purchase | 2022-12-31 | 13G | Whitehawk Therapeutics Inc WHWK | Satter Muneer A | 1,630,830 6.700% | 336,045 (+25.95%) | Filing History |
| 2023-01-17 4:59 pm Purchase | 2023-01-01 | 13D | Whitehawk Therapeutics Inc WHWK | Desai Neil | 2,635,196 10.800% | 36,755 (+1.41%) | Filing History |
| 2022-10-04 4:01 pm Purchase | 2022-09-26 | 13G | Whitehawk Therapeutics Inc WHWK | Satter Muneer A | 1,294,785 5.300% | 1,294,785 (New Position) | Filing History |
| 2022-09-26 5:27 pm Purchase | 2022-09-22 | 13D | Whitehawk Therapeutics Inc WHWK | Avoro Capital Advisors LLC | 3,471,752 14.400% | 1,260,000 (+56.97%) | Filing History |
| 2022-02-14 4:13 pm Purchase | 2021-08-26 | 13G | Whitehawk Therapeutics Inc WHWK | Venrock Healthcare Capital Partners II, L.P. | 1,529,402 7.300% | 1,529,402 (New Position) | Filing History |
| 2022-02-11 7:33 pm Sale | 2021-12-31 | 13G | Whitehawk Therapeutics Inc WHWK | BIOTECHNOLOGY VALUE FUND L P | 899,392 4.300% | -247,660 (-21.59%) | Filing History |
| 2022-02-11 5:20 pm Sale | 2021-12-31 | 13G | Whitehawk Therapeutics Inc WHWK | Vivo Panda LLC | 727,667 3.500% | -113,504 (-13.49%) | Filing History |
| 2022-02-09 3:15 pm Purchase | 2021-12-31 | 13G | Whitehawk Therapeutics Inc WHWK | VANGUARD GROUP INC | 761,473 3.640% | 761,473 (New Position) | Filing History |
| 2021-11-15 4:33 pm Sale | 2021-11-15 | 13G | Aerpio Pharmaceuticals, Inc. ARPO | RA Capital Management, L.P. | 0 0.000% | -165,749 (Position Closed) | Filing History |
| 2021-11-12 4:03 pm Sale | 2021-11-10 | 13D | Whitehawk Therapeutics Inc WHWK | Satter Muneer A | 374,785 1.790% | -4 (-0.00%) | Filing |
| 2021-09-08 5:30 pm Purchase | 2021-08-26 | 13D | Whitehawk Therapeutics Inc WHWK | Desai Neil | 2,598,441 12.400% | 2,598,441 (New Position) | Filing History |
| 2021-09-07 5:26 pm Purchase | 2021-08-26 | 13G | Whitehawk Therapeutics Inc WHWK | BIOTECHNOLOGY VALUE FUND L P | 1,147,052 5.500% | 1,147,052 (New Position) | Filing History |
| 2021-09-07 5:25 pm Purchase | 2021-08-26 | 13D | Whitehawk Therapeutics Inc WHWK | ACUTA CAPITAL PARTNERS LLC | 1,548,081 7.300% | 1,548,081 (New Position) | Filing History |
| 2021-09-03 4:47 pm Sale | 2021-08-26 | 13D | Whitehawk Therapeutics Inc WHWK | ORBIMED ADVISORS LLC | 346,262 1.700% | -1 (-0.00%) | Filing |
| 2021-09-02 4:30 pm Purchase | 2021-08-26 | 13G | Whitehawk Therapeutics Inc WHWK | Vivo Panda LLC | 841,171 4.000% | 841,171 (New Position) | Filing History |
| 2021-08-30 5:27 pm Purchase | 2021-08-26 | 13D | Whitehawk Therapeutics Inc WHWK | Avoro Capital Advisors LLC | 2,211,752 10.700% | 2,211,752 (New Position) | Filing History |
| 2021-08-23 4:30 pm Purchase | 2021-08-11 | 13G | Aerpio Pharmaceuticals, Inc. ARPO | RA Capital Management, L.P. | 165,749 5.220% | 60,762 (+57.88%) | Filing History |